Foley Team Represents Displaced Barry Farm Residents in Pro Bono Civil Rights Case
August 29, 2017
Partner Joe Edmondson and Senior Counsel Brian Kapatkin, along with a team of Foley lawyers, are representing the residents of the Barry Farm public housing community in Washington DC in a housing discrimination case that was filed in the U.S. District Court for the District of Columbia. The pro bono case is being handled in conjunction with the Washington Lawyers’ Committee for Civil Rights and Urban Affairs and carries on the firm’s longstanding tradition of working with the WLC on significant civil rights litigation.
The case seeks to remedy the discriminatory impact that the plan for redeveloping Barry Farm will have on families with children who live there. “We allege violations of the federal Fair Housing Act and the D.C. Human Rights Act, based on the concern that the families will be displaced without sufficient units set aside to allow them to return. The case will also address serious conditions issues at Barry Farm for all residents while it is undergoing redevelopment, including under the U.S. Housing Act,” Edmondson said.
Read more about the case here and here.
The case seeks to remedy the discriminatory impact that the plan for redeveloping Barry Farm will have on families with children who live there. “We allege violations of the federal Fair Housing Act and the D.C. Human Rights Act, based on the concern that the families will be displaced without sufficient units set aside to allow them to return. The case will also address serious conditions issues at Barry Farm for all residents while it is undergoing redevelopment, including under the U.S. Housing Act,” Edmondson said.
Read more about the case here and here.
People
Related News
October 9, 2026
In the News
Jonathan Lasken Highlighted Across the Media for Arrival to Foley
Foley & Lardner LLP partner Jonathan Lasken is highlighted across the media for his recent arrival to the firm’s Washington D.C. office.
October 7, 2026
In the News
William Holtz Examines New FDA Approach to Clinical Trial Development
Foley & Lardner LLP of counsel William Holtz is quoted in the PharmaVoice article, “5 Key Facts About the FDA Expedited IND Pilot Program,” examining the FDA's new pilot program and its potential to accelerate clinical research.
October 5, 2026
In the News
Louis Lehot Analyzes U.S. IPO Market Trends and Outlook
Foley & Lardner LLP partner Louis Lehot is featured in the Daily Journal‘s Capital & Counsel newsletter offering insights on the current state of the U.S. IPO market and the factors influencing companies' routes to going public.